NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 39 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,930 | +17.3% | 10,000 | 0.0% | 0.00% | – |
| Q2 2023 | $12,725 | -5.1% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $13,415 | -22.8% | 10,000 | -9.1% | 0.00% | – |
| Q4 2022 | $17,367 | +2.2% | 11,000 | -8.3% | 0.00% | – |
| Q3 2022 | $17,000 | +88.9% | 12,000 | +71.4% | 0.00% | – |
| Q2 2022 | $9,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | +12.5% | 7,000 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -11.1% | 7,000 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | +800.0% | 7,000 | +600.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |